NCT Number: NCT00326040
A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects
The purpose of this study is to evaluate the safety and efficacy of the iStent trabecular micro-bypass stent in reducing intraocular pressure (IOP) in refractory open-angle glaucoma subjects.
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
University of Cologne, Cologne, Germany
About this study
Glaukos Corporation conducted a clinical research study at multiple (approximately 7) investigational sites within Europe.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Diagnosed with primary open-angle glaucoma (POAG)
- Subject on maximally tolerated medical therapy or where noncompliance with medication has been document
- Subject has failed a conventional glaucoma surgical procedure. (trabeculectomy, Trabeculoplasty(ALT), viscocanalostomy, collagen implant)
Exclusion criteria
- Angle closure glaucoma
- Fellow eye already enrolled
Treatment and study plan
Primary outcomes
-
Efficacy
Time frame: 24 months
Sponsors and collaborators
Lead sponsor
Glaukos Corporation
Industry
Registry information
Official study title
A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects.
Important dates
- Study start
- 2003
- Study completion
- 2007
- First posted
- May 16, 2006
- Registry last updated
- Jul 25, 2008
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma
NCT05411198
Eye Diseases, Glaucoma
Fayetteville, Arkansas, United States
View Trial DetailsHydrus Microstent for Refractory Open-Angle Glaucoma
NCT03267134
Eye Diseases, Glaucoma
Fayetteville, Arkansas, United States
View Trial DetailsA Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
NCT01699464
Eye Diseases, Glaucoma
View Trial DetailsA Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients
NCT00856622
Eye Diseases, Glaucoma
Aachen, Germany
View Trial Details